MENU Quick Go

  • HOME
  • News
  • PharmAbcine Notice
PharmAbcine Notice
Total 167 search
No. Subject Date Count
167 PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT. 2017-07-07 310
166 Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present for ``Investor Relation`` at MIRAE ASSET DAEWOO SECURITIES Corporate Day on July 12th, 2017. 2017-07-07 212
165 Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with Bio-Pod 2017-05-10 399
164 Dr. Jin-San Yoo, CEO of PharmAbcine is presenting at the forum for future pharm in Seoul on June 23, 2017. 2017-05-10 384
163 Dr. Jin-San Yoo, CEO of PharmAbcine is presenting PharmAbcine`s R&D progress and the interim data of the ongoing phase IIa recurrent GBM trial at 2017 Bio International Convention in San Diego on June 19-22, 2017. 2017-05-10 323
162 Dr. Lawrence Cher, principle investigator of Tanibirumab phase IIa recurrent GBM trial in Australia expose the interim data of the ongoing trial at ASCO 2017 Annual Meeting in Chicago on June 2-6, 2017. 2017-05-10 346
161 Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present PharmAbcine`s R&D progress at BIO LOGISTICS WORLD KOREA in Seoul on May 23-24, 2017. 2017-05-10 191
160 Dr. Jin-San Yoo, CEO of PharmAbcine is serving as an expert of MAB working group of EDQM observer representing Republic of Korea. 2017-04-05 397
159 Dr. Jin-San Yoo, CEO of PharmAbcine is serving as an officer for Bio at the Med term Strategy and planning for pharma industry. 2017-04-05 330
158 Dr. Jin-San Yoo, CEO of PharmAbcine will be awarded for the contribution of Health-Medical by KHIDI President on April 13th, 2017. 2017-04-05 333
1 2 3 4 5 6 7 8 9 10